GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93020C00039UNIVERSITY OF MONTANA

Overview

Award facts

Net obligations
$25.92M
$25,915,968of $33.42M potential value
Outlays (paid to date)
$15.93M
$15.93M paid of $25.92M obligated$15,932,376
Period of performance
Sep 30, 2020 to Sep 29, 2027
Ends in 10 months
Modifications
10
Latest action Jul 27, 2026
Contract type
Definitive contract
PIID 75N93020C00039

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.

Dates and value

Award date
Signed on Aug 27, 2020
Current value
$25,915,968Base and exercised options
Potential value (if all options are exercised)
$33,419,572

Obligations by fiscal year of action

  • FY2023: $8,155,829
  • FY2022: $7,352,416
  • FY2020: $10,407,723

Total across 3 fiscal years: $25,915,968

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 27, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationMISSOULA, MT
UEIDAY7Z8ZD48Q3
CAGE code4B839
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyUNIVERSITY OF MONTANA

Business types and certifications

Educational institutionU.S. government entity

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885); Nih reimbursable - otherProgram activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Missoula, Montana 59812-0003
Congressional district (place of performance)
MT-01As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
9

Solicitation and notices

Solicitation ID
BAA-DAIT-75N93019R00009
Solicitation date
Mar 20, 2019
Notices

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 27, 2020Base obligation at award: $10,407,723
Latest action
Jul 27, 2026 — Other administrative actionModification P00010; administrative: no change in scope or value
Latest substantive action
Aug 3, 2023 — Option exercisedModification P00006; obligation change +$8,155,829
Actions by type
  • Base award1
  • Other administrative action8
  • Option exercised2
11 actions recorded, Aug 27, 2020 to Jul 27, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
11

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2020-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression